# Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma

> **NCT02648633** · PHASE1 · TERMINATED · sponsor: **University of Virginia** · enrollment: 4 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **RADIATION:** Stereotactic Radiosurgery
- **DRUG:** Nivolumab
- **DRUG:** Valproate

## Key facts

- **NCT ID:** NCT02648633
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05-24
- **Primary completion:** 2017-02-21
- **Final completion:** 2017-02-21
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** The pharmaceutical company (BMS) would no longer provide nivolumab for the study, so the study was terminated early.
- **Last updated:** 2017-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02648633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02648633, "Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02648633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*